A non-interventional survey on the EGFR (epidermal growth factor receptor) mutation status in completely resected Chinese Non-Small Cell Lung Cancer (NSCLC) patients with adenocarcinoma histology - ICAN
Study identifier:NIS-OCN-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A non-interventional survey on the Epidermal Growth Factor Receptor (EGFR) mutation status in completely resected Chinese Non-Small Cell Lung Cancer (NSCLC) patients with adenocarcinoma histology
Medical condition
Non-small Cell Lung Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
591
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Aug 2010
Primary Completion Date: 01 Jan 2014
Study Completion Date: 01 Jan 2014
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients in this group should be histological confirmed adenocarcinoma of the lung, have received complete resection and tested for EGFR mutation. | - |
Contacts
Investigators
Principal Investigator
Karen Atkin
Astrazeneca China R&D
